Interpretation of guidelines for the diagnosis and comprehensive treatment of colorectal cancer liver metastases in China(v2013).
- Author:
Dexiang ZHU
1
,
2
,
3
;
Li REN
;
Jianmin XU
Author Information
1. Department of General Surgery, Zhongshan Hospital, Fudan University
2. Institute of General Surgery, Fudan University
3. Colorectal Cancer Research Center, Fudan University, Shanghai 200032, China. xujmin@aliyun.com.
- Publication Type:Journal Article
- MeSH:
China;
Colorectal Neoplasms;
pathology;
Humans;
Liver Neoplasms;
diagnosis;
secondary;
therapy;
Practice Guidelines as Topic
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(6):525-529
- CountryChina
- Language:Chinese
-
Abstract:
In recent years there have been great developments in the diagnosis and comprehensive treatment of colorectal cancer liver metastases (CRLM). Guidelines for the Diagnosis and Comprehensive Treatment of Colorectal Cancer Liver Metastases were compiled to standardize and improve the diagnosis and treatment outcomes in China. This paper summarizes the updated content in the Guideline (V.2013). We should conduct gene testing related to CRLM to guide individual treatment, emphasize the role of the multidisciplinary team, and select molecular targeted drugs reasonably. In addition, we discuss the operative timing of CRLM, minimally invasive operation and regional therapy of liver metastases.
